Insights

Innovative Pipeline Sea Pharmaceuticals' focus on developing novel synthetic small molecules targeting the glutamate neurotransmitter system positions them at the forefront of neurotherapeutics innovation, presenting opportunities for partnerships in drug development, research collaborations, and advanced formulation support.

Niche Market Focus Specializing in treatments for high-need conditions like tinnitus, epilepsy, and sporadic ALS, Sea offers potential for customized supply chain solutions, specialized manufacturing, and clinical-grade raw materials to support their targeted therapies.

Growing Venture With recent funding of $417K and revenue between 1 to 10 million USD, Sea is in an expansion phase, creating opportunities to provide scalable manufacturing services, R&D tools, or dosage form innovations tailored to early-stage biotech growth.

Leverage industry connections The company's board includes leaders from top biotech and pharmaceutical firms, suggesting opportunities for strategic alliances, licensing deals, or co-development projects with experienced industry veterans.

Technology-Driven Approach Utilizing advanced cloud and web technologies such as Google Cloud CDN, Sentry, and HTTP/3, Sea Pharmaceuticals demonstrates a commitment to innovative digital solutions, opening possibilities for delivering cutting-edge digital health tools, data analytics, and precision medicine support.

Similar companies to Sea Pharmaceuticals LLC

Sea Pharmaceuticals LLC Tech Stack

Sea Pharmaceuticals LLC uses 8 technology products and services including Google Cloud CDN, Webpack, Sirvoy, and more. Explore Sea Pharmaceuticals LLC's tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • Webpack
    Development
  • Sirvoy
    Hotel Management
  • Sentry
    Issue Trackers
  • Envoy
    Load Balancers
  • WebsiteBuilder
    Page Builders
  • Bootstrap
    UI Frameworks
  • HTTP/3
    Web & Portal Technology

Media & News

Sea Pharmaceuticals LLC's Email Address Formats

Sea Pharmaceuticals LLC uses at least 1 format(s):
Sea Pharmaceuticals LLC Email FormatsExamplePercentage
FLast@seapharmaceuticals.comJDoe@seapharmaceuticals.com
57%
FirstLast@seapharmaceuticals.comJohnDoe@seapharmaceuticals.com
43%

Frequently Asked Questions

Where is Sea Pharmaceuticals LLC's headquarters located?

Minus sign iconPlus sign icon
Sea Pharmaceuticals LLC's main headquarters is located at Cambridge, Massachusetts 02138 United States. The company has employees across 3 continents, including North AmericaAfricaAsia.

What is Sea Pharmaceuticals LLC's official website and social media links?

Minus sign iconPlus sign icon
Sea Pharmaceuticals LLC's official website is seapharmaceuticals.com and has social profiles on LinkedInCrunchbase.

What is Sea Pharmaceuticals LLC's NAICS code?

Minus sign iconPlus sign icon
Sea Pharmaceuticals LLC's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sea Pharmaceuticals LLC have currently?

Minus sign iconPlus sign icon
As of April 2026, Sea Pharmaceuticals LLC has approximately 10 employees across 3 continents, including North AmericaAfricaAsia. Key team members include President, Ceo, Chief Science Officer (cso), Founder, Director (biologist And Pharmacologist): J. P. P.Head Of Digital Technology: D. H.Distinguished Clinical Scientist: A. F. C.. Explore Sea Pharmaceuticals LLC's employee directory with LeadIQ.

What industry does Sea Pharmaceuticals LLC belong to?

Minus sign iconPlus sign icon
Sea Pharmaceuticals LLC operates in the Pharmaceutical Manufacturing industry.

What technology does Sea Pharmaceuticals LLC use?

Minus sign iconPlus sign icon
Sea Pharmaceuticals LLC's tech stack includes Google Cloud CDNWebpackSirvoySentryEnvoyWebsiteBuilderBootstrapHTTP/3.

What is Sea Pharmaceuticals LLC's email format?

Minus sign iconPlus sign icon
Sea Pharmaceuticals LLC's email format typically follows the pattern of FLast@seapharmaceuticals.com. Find more Sea Pharmaceuticals LLC email formats with LeadIQ.

How much funding has Sea Pharmaceuticals LLC raised to date?

Minus sign iconPlus sign icon
As of April 2026, Sea Pharmaceuticals LLC has raised $417K in funding. The last funding round occurred on Feb 10, 2025 for $417K.

When was Sea Pharmaceuticals LLC founded?

Minus sign iconPlus sign icon
Sea Pharmaceuticals LLC was founded in 2013.

Sea Pharmaceuticals LLC

Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees

Privately held neurotherapeutics company founded in March 2013 by J.P. Pearson and E.J. Martinez and operated in Cambridge Massachusetts USA. Sea Pharmaceuticals LLC conducts research, development, and-commercialization (R-&-D-&-C) of Sea's novel proprietary synthetic small molecules targeting glutamate neurotransmitter system in neurology disorders. Sea is advancing orally administered potential treatments for high need constant bothersome tinnitus (CBT), Epilepsy, and sporadic Amyotrophic Lateral Sclerosis (S-ALS). Sea has 1 emeritus board member EBM & 7 board members. Benjamin F Cravatt PhD is Sea’s emeritus board member. Ben is neurochemist/ biologist Professor Scripps Research Institute and member NAS (USA National Academy Sciences); Ben founded >10 biotech co’s ActivX, Abide / Lundbeck, Vividion /Bayer, et al.; Sea's 7 board members: (i) Eric R Olson PhD molecular biologist, pharmacologist, trustee Cystic Fibrosis Foundation CFF; drug maker led R-&-D-&-C at Vertex VRTX to 4 life-saving CF drugs Kalydeco, Orkambi, Symdeco, Trikafta; former Aurora/ Vertex, Syros, Upjohn, Warner-Lambert/ Parke-Davis; (ii) Mark G Currie PhD molecular pharmacologist; on board IRWD; former CSO, President Ironwood Pharma Inc; Cyclerion Inc, Sepracor, Monsanto; Mark led R-&-D-&-C teams to drugs Celebrex, Bextra, Deramaxx (veterinary), Dynastat (Europe/Asia), Lunesta, Xopenex, Linzess / Constella (EU); (iii) W. Kendall Brown JD Cal-Tech trained physicist; lawyer Brown Associates Des Moines Iowa; computer scientist Advanced Logic Systems; IBM, California, (iv) Michael J Higgins MBA on several boards; was COO CFO Ironwood / Microbia; VP Genzyme, VP Procept); (v) Shaker Sadasivam PhD, MBA engineer formerly CEO Sun Edison Semi -Conductor (SEMI) Monsanto; on boards several co.; (vi) Nabil Elkouh PhD engineer, metals / batteries expert, CEO Conamix; Erigo Tech LLC, American Titanium Works (ATW); (vii) James P Pearson, President & CEO, Sea. See more at https://www.seapharmaceuticals.com

Section iconCompany Overview

Headquarters
Cambridge, Massachusetts 02138 United States
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $417K

    Sea Pharmaceuticals LLC has raised a total of $417K of funding over 3 rounds. Their latest funding round was raised on Feb 10, 2025 in the amount of $417K.

  • $1M$10M

    Sea Pharmaceuticals LLC's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $417K

    Sea Pharmaceuticals LLC has raised a total of $417K of funding over 3 rounds. Their latest funding round was raised on Feb 10, 2025 in the amount of $417K.

  • $1M$10M

    Sea Pharmaceuticals LLC's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.